Citadel Advisors’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-13,579
| Closed | -$27.3K | – | 7026 |
|
2024
Q3 | $27.3K | Buy |
+13,579
| New | +$27.3K | ﹤0.01% | 5271 |
|
2023
Q3 | – | Hold |
0
| – | – | – | 6668 |
|
2023
Q2 | – | Sell |
-62
| Closed | -$1.06K | – | 6630 |
|
2023
Q1 | $1.06K | Sell |
62
-1,780
| -97% | -$30.3K | ﹤0.01% | 5765 |
|
2022
Q4 | $48.4K | Sell |
1,842
-329
| -15% | -$8.64K | ﹤0.01% | 5291 |
|
2022
Q3 | $221K | Sell |
2,171
-237
| -10% | -$24.1K | ﹤0.01% | 4787 |
|
2022
Q2 | $340K | Buy |
2,408
+266
| +12% | +$37.6K | ﹤0.01% | 4519 |
|
2022
Q1 | $338K | Sell |
2,142
-2,643
| -55% | -$417K | ﹤0.01% | 4830 |
|
2021
Q4 | $1.06M | Buy |
4,785
+1,898
| +66% | +$421K | ﹤0.01% | 3758 |
|
2021
Q3 | $557K | Sell |
2,887
-754
| -21% | -$145K | ﹤0.01% | 4413 |
|
2021
Q2 | $875K | Sell |
3,641
-97
| -3% | -$23.3K | ﹤0.01% | 4148 |
|
2021
Q1 | $1.27M | Buy |
3,738
+2,328
| +165% | +$790K | ﹤0.01% | 3662 |
|
2020
Q4 | $505K | Sell |
1,410
-1,455
| -51% | -$521K | ﹤0.01% | 3852 |
|
2020
Q3 | $1.32M | Buy |
+2,865
| New | +$1.32M | ﹤0.01% | 2675 |
|